Anti-influenza virus agents: synthesis and mode of action.
about
An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virusInhibition of influenza H7 hemagglutinin-mediated entryInhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR PathwayMutagenesis studies of the H5 influenza hemagglutinin stem loop region.Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.Recent advances in neuraminidase inhibitor development as anti-influenza drugs.Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus.Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.Rapid and specific influenza virus detection by functionalized magnetic nanoparticles and mass spectrometry.Discovery and SAR study of piperidine-based derivatives as novel influenza virus inhibitors.In vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination.Characterization of influenza hemagglutinin interactions with receptor by NMR.Evidence for a novel gene associated with human influenza A viruses.Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus(1-Adamant-yl)(3-amino-phen-yl)methanone.Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.Mechanisms of action and efficacy of statins against influenza.Emerging antiviral drugsMacromolecular (pro)drugs in antiviral research
P2860
Q26771734-A95B03C1-EE5D-4E54-8B5A-91B3F92108F1Q27675846-1A699F39-58B4-4E29-8BC1-4BA89636C4F6Q28534616-69CF1C0E-E59D-43CC-8030-8F9361F617FDQ30151464-B860F16F-5CF5-4359-959C-B5722E264EFAQ30363789-3BB1685B-7EE6-4BD7-A170-B037573809DDQ30369353-2B9D3318-213C-4C4E-B01B-AFF8AE946959Q30419301-E2D05307-9827-47F0-AB04-800A134EAFD1Q30427556-3F0EFADC-9FD5-48A6-A2F0-3AFEBAA6DFE3Q33452730-3ECC1D77-3DC4-4A69-9CF7-3CC22A280D2AQ33866738-3E650D87-6B10-4F8D-ABC7-33ED1AB69490Q34075986-6FA0AAE4-7C3D-42D9-B890-C70131C5D9C2Q34253013-461D2483-8B00-4E49-A7B5-135FF1A78976Q34341508-1163F238-64FF-43DB-A029-A5E10FF027D2Q34344583-B103899B-F6A2-4A43-BA18-12AA7A4DD1BDQ37428264-04E13DF1-CE04-4176-A9DE-35816F3CCB4BQ37450711-EBCD5B38-E461-405D-9F01-65A7FE579F66Q38452544-50713CCA-4446-455F-9B9F-A03CCF4EF11AQ38790676-B4077089-EA48-4CDF-9B71-A9BAA2FA2736Q39776237-7A91CA27-11F0-4C4B-8A37-4CEB155E859AQ39816982-B7EECA5F-417F-46A2-A1AB-80BE6B67BCA4Q41763032-4DCD614F-C2C1-4CD1-B6EC-3C4ED8E8882DQ41781195-B26414A4-C974-4074-BA1F-525C7582B511Q42177559-58638E10-6C73-4B9C-8934-035767A7F1D2Q56786308-74D6159F-F48D-4AAF-81F7-156AADEA2E40Q57376798-DFCB992B-0588-4101-BBAF-68C84B1F8B07
P2860
Anti-influenza virus agents: synthesis and mode of action.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Anti-influenza virus agents: synthesis and mode of action.
@ast
Anti-influenza virus agents: synthesis and mode of action.
@en
type
label
Anti-influenza virus agents: synthesis and mode of action.
@ast
Anti-influenza virus agents: synthesis and mode of action.
@en
prefLabel
Anti-influenza virus agents: synthesis and mode of action.
@ast
Anti-influenza virus agents: synthesis and mode of action.
@en
P2860
P356
P1476
Anti-influenza virus agents: synthesis and mode of action.
@en
P2093
Irene M Lagoja
P2860
P356
10.1002/MED.20096
P577
2008-01-01T00:00:00Z